Retraction notice to “Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers” [Biochem. Pharmacol. 79 (2010) 218–228]

Affiliations

¹ Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States
² Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States
³ Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States

Sheeja T. Tharakan et al. Biochem Pharmacol. 2016.

. 2016 Feb 15:102:145.

doi: 10.1016/j.bcp.2015.11.010. Epub 2016 Feb 20.

¹ Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States
² Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States
³ Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States

No abstract available

Retraction of

Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers.
Tharakan ST, Inamoto T, Sung B, Aggarwal BB, Kamat AM. Tharakan ST, et al. Biochem Pharmacol. 2010 Jan 15;79(2):218-28. doi: 10.1016/j.bcp.2009.08.007. Epub 2009 Aug 12. Biochem Pharmacol. 2010. Retraction in: Biochem Pharmacol. 2016 Feb 15;102:145. doi: 10.1016/j.bcp.2015.11.010. PMID: 19682434 Free PMC article. Retracted.